To prove the importance of the JAK pathway, someone needed to discover a compound to test the hypothesis that inhibiting the JAK enzyme was of value in treating disease.
When Epiphany Biosciences, a tiny San Francisco drug developer, was looking for a hepatitis C antiviral compound to test in the lab, it could have saved a few thousand bucks by hiring test tube drones from India.